Mammographic screening and risk factors for breast cancer.
暂无分享,去创建一个
[1] M. Pike,et al. Ethnic differences in the use of regular mammography: the multiethnic cohort , 2009, Breast Cancer Research and Treatment.
[2] Lewis H Kuller,et al. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. , 2008, American journal of epidemiology.
[3] J. Palmgren,et al. On informative detection bias in screening studies , 2008, Statistics in medicine.
[4] S. Weitzen,et al. "Weighing in" on screening mammography , 2008 .
[5] Lewis H Kuller,et al. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. , 2008, American journal of epidemiology.
[6] J. Manson,et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. , 2008, JAMA.
[7] Karla Kerlikowske,et al. Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.
[8] D. Miglioretti,et al. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. , 2007, Journal of the National Cancer Institute.
[9] Karla Kerlikowske,et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.
[10] J. Robins,et al. Estimating causal effects from epidemiological data , 2006, Journal of Epidemiology and Community Health.
[11] D. Berry,et al. Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .
[12] Albert W Wu,et al. The influence of health status, age, and race on screening mammography in elderly women. , 2005, Archives of internal medicine.
[13] J. Hux,et al. Reduced screening mammography among women with diabetes. , 2005, Archives of internal medicine.
[14] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[15] Roger B. Davis,et al. Obesity and breast cancer screening , 2004, Journal of General Internal Medicine.
[16] Graham A Colditz,et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.
[17] M. Joffe. Invited commentary: screening as a nuisance variable in cancer epidemiology: methodological considerations. , 2003, American journal of epidemiology.
[18] N. Weiss. Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. , 2003, American journal of epidemiology.
[19] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[20] S. Cole,et al. Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. , 2002, American journal of epidemiology.
[21] G. Colditz,et al. Postmenopausal Hormone Use, Screening, and Breast Cancer: Characterization and Control of a Bias , 2001, Epidemiology.
[22] D. Allison,et al. Body weight and cancer screening among women. , 2001, Journal of women's health & gender-based medicine.
[23] G. Colditz,et al. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.
[24] J. Robins,et al. Marginal Structural Models and Causal Inference in Epidemiology , 2000, Epidemiology.
[25] Daniel S. Miller,et al. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)--Behavioral Risk Factor Surveillance System. , 1999, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[26] J Schwartz,et al. Air pollution and hospital admissions for heart disease in eight U.S. counties. , 1998, Epidemiology.
[27] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[28] G A Colditz,et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.
[29] R. Hoover,et al. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States) , 1994, Cancer Causes & Control.
[30] J. Robins,et al. Identifiability and Exchangeability for Direct and Indirect Effects , 1992, Epidemiology.
[31] S. Thacker,et al. A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .
[32] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[33] Use of mammograms among women aged > or = 40 years--United States, 2000-2005. , 2007, MMWR. Morbidity and mortality weekly report.
[34] J. Pearl,et al. Causal diagrams for epidemiologic research. , 1999, Epidemiology.
[35] G. Shaw,et al. Maternal pesticide exposure from multiple sources and selected congenital anomalies. , 1999 .